Repligen (RGEN) Reports In-Line Q4 EPS, Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $138.57 -2.69%
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $51.9 million versus the consensus estimate of $50.4 million.
GUIDANCE:
Repligen sees FY2019 EPS of $0.81-$0.86, versus the consensus of $0.85. Repligen sees FY2019 revenue of $218-225 million, versus the consensus of $217.25 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
